Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Immunogenetic contributions to recurrent pregnancy loss.

Grimstad F, Krieg S.

J Assist Reprod Genet. 2016 Jul;33(7):833-47. doi: 10.1007/s10815-016-0720-6. Epub 2016 May 12. Review.

PMID:
27169601
2.

Inheritance of the 8.1 ancestral haplotype in recurrent pregnancy loss.

Kolte AM, Nielsen HS, Steffensen R, Crespi B, Christiansen OB.

Evol Med Public Health. 2015 Dec 16;2015(1):325-31. doi: 10.1093/emph/eov031. Print 2015.

3.

The Effects of Intravenous Immunoglobulins in Women with Recurrent Miscarriages: A Systematic Review of Randomised Trials with Meta-Analyses and Trial Sequential Analyses Including Individual Patient Data.

Egerup P, Lindschou J, Gluud C, Christiansen OB; ImmuReM IPD Study Group..

PLoS One. 2015 Oct 30;10(10):e0141588. doi: 10.1371/journal.pone.0141588. eCollection 2015. Review.

4.

Number of sons contributes to ageing-associated inflammation.

Marttila S, Nevalainen T, Kananen L, Jylhävä J, Jylhä M, Hervonen A, Ilonen J, Hurme M.

Sci Rep. 2015 Feb 27;5:8631. doi: 10.1038/srep08631.

5.

Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.

Christiansen OB.

Clin Exp Immunol. 2014 Dec;178 Suppl 1:120-2. doi: 10.1111/cei.12536. No abstract available.

6.

Clinical impact of H-Y alloimmunity.

Popli R, Sahaf B, Nakasone H, Lee JY, Miklos DB.

Immunol Res. 2014 May;58(2-3):249-58. doi: 10.1007/s12026-014-8514-3. Review.

7.

To drive or be driven: the path of a mouse model of recurrent pregnancy loss.

Bonney EA, Brown SA.

Reproduction. 2014 Apr 8;147(5):R153-67. doi: 10.1530/REP-13-0583. Print 2014 May. Review.

8.

The human placental sexome differs between trophoblast epithelium and villous vessel endothelium.

Cvitic S, Longtine MS, Hackl H, Wagner K, Nelson MD, Desoye G, Hiden U.

PLoS One. 2013 Oct 29;8(10):e79233. doi: 10.1371/journal.pone.0079233. eCollection 2013.

9.

Maternal CD4⁺ and CD8⁺ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice.

Perchellet AL, Jasti S, Petroff MG.

Biol Reprod. 2013 Oct 31;89(4):102. doi: 10.1095/biolreprod.113.110445. Print 2013 Oct.

10.

New insights into mechanisms behind miscarriage.

Larsen EC, Christiansen OB, Kolte AM, Macklon N.

BMC Med. 2013 Jun 26;11:154. doi: 10.1186/1741-7015-11-154. Review.

11.

Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy.

Linscheid C, Petroff MG.

Am J Reprod Immunol. 2013 Apr;69(4):304-14. doi: 10.1111/aji.12075. Epub 2013 Feb 8. Review.

12.

Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, Chamley LW, Petroff MG.

Am J Pathol. 2012 Jan;180(1):256-66. doi: 10.1016/j.ajpath.2011.09.021. Epub 2011 Nov 8.

13.

Review: Fetal antigens--identity, origins, and influences on the maternal immune system.

Petroff MG.

Placenta. 2011 Mar;32 Suppl 2:S176-81. doi: 10.1016/j.placenta.2010.12.014. Epub 2011 Jan 5. Review.

14.

H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male : female ratio in subsequent live births.

Nielsen HS, Wu F, Aghai Z, Steffensen R, van Halteren AG, Spierings E, Christiansen OB, Miklos D, Goulmy E.

Hum Reprod. 2010 Nov;25(11):2745-52. doi: 10.1093/humrep/deq242. Epub 2010 Sep 7.

15.

Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial.

Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C.

Hum Reprod. 2010 Sep;25(9):2203-9. doi: 10.1093/humrep/deq179. Epub 2010 Jul 15.

Supplemental Content

Support Center